Target intelligence / Profile preview

Pyrimidine-pyrimidone (6-4) photoproduct (6-4PP)

Target
6-4PP
Molecular classification
DNA lesion, DNA damage product, Pyrimidine dimer
01

Overview

Pyrimidine-pyrimidone (6-4) photoproducts (6-4PPs) are a major class of DNA lesions caused by exposure to ultraviolet (UV) radiation, particularly UVB. They are formed by a photochemical reaction between two adjacent pyrimidines (thymine or cytosine), resulting in a covalent bond between the C6 position of the 5' base and the C4 position of the 3' base. Although they occur less frequently than cyclobutane pyrimidine dimers (CPDs), 6-4PPs cause significant structural distortion of the DNA helix, which typically allows them to be recognized and repaired more efficiently by the nucleotide excision repair (NER) pathway. If these lesions persist, they can lead to characteristic C-to-T transition mutations during DNA replication, which are primary drivers of skin cancers such as melanoma and non-melanoma skin cancers. Therapeutic strategies targeting 6-4PPs often involve the topical application of DNA repair enzymes, such as photolyases or T4 endonuclease V, to accelerate the removal of these lesions and reduce the risk of UV-induced malignancy.

Other names
6-4 photoproductPyrimidine-pyrimidone dimerUV-induced DNA lesion6-4 pyrimidine-pyrimidone photoproduct
02

Mechanism of action

Direct enzymatic repair of DNA lesions via nucleotide excision repair (NER) enhancement or direct reversal by exogenous DNA repair enzymes (e.g., photolyases) delivered topically to prevent mutagenesis and carcinogenesis.

03

Biological functions

MutagenesisCell cycle arrestApoptosis inductionTranscription inhibitionDNA replication block
04

Disease associations

Skin cancerMelanomaBasal cell carcinomaSquamous cell carcinomaXeroderma pigmentosumPhotoaging
05

Safety considerations

Mutagenic potential if unrepairedCarcinogenic riskGenotoxicityImmunosuppression induced by DNA damage
06

Interacting drugs

T4 endonuclease V (T4N5)

2 more in the full profile.

07

Biomarkers

6-4PP DNA adduct levelsC-to-T transition mutationsCyclobutane pyrimidine dimer (CPD) levels

Beyond the preview

Go deeper on Pyrimidine-pyrimidone (6-4) photoproduct (6-4PP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyrimidine-pyrimidone (6-4) photoproduct (6-4PP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call